Premarket Gainers - Top Stocks Before Market Open (2024)

Avalo Therapeutics, Inc.2 days ago

AVALO REPORTS 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

News

wayne, pa. and rockville, md., march 29, 2024 (globe newswire) -- avalo therapeutics, inc. (nasdaq: avtx), today announced business updates and year-end financial results for 2023.

Kidpik Corp.6 days ago

KIDPIK REGAINS COMPLIANCE WITH THE NASDAQ MINIMUM BID PRICE REQUIREMENT

News

new york--(business wire)--kidpik corp. (nasdaq: pik) ("kidpik” or the "company"), an online clothing subscription-based e-commerce company, today announced that the company received written notification from the listing qualification department of the nasdaq stock market llc (“nasdaq”) notifying the company that is has regained full compliance with the minimum bid price requirement. effective march 7, 2024, the company affected a 1-for-5 reverse stock split of our outstanding stock in an effor.

Akanda Corp.3 days ago

AKANDA CORP. ANNOUNCES CANMART'S PLANS FOR FACEBOOK AND INSTAGRAM SOCIAL SHOPPING TECHNOLOGY INTEGRATION

News

london, united kingdom--(newsfile corp. - march 28, 2024) - akanda corp. ("akanda" or the "company") (nasdaq: akan), an international medical cannabis company, akanda corp. announced its wholly-owned united kingdom (uk) subsidiary, canmart, plans to develop its social shopping capability by integrating with meta, to create a user friendly buying experience for facebook and instagram users to purchase canmart products. in short, this integration allows facebook and instagram users to browse products featured in canmart shoppable videos, place products in a native shopping cart and checkout - all without leaving facebook or instagram.

Serina Therapeutics, Inc.5 days ago

SERINA THERAPEUTICS ANNOUNCES COMPLETION OF MERGER WITH AGEX THERAPEUTICS

News

huntsville, ala., march 26, 2024 (globe newswire) -- serina therapeutics (nyse american: ser), a clinical-stage biotechnology company developing a pipeline of therapies for the treatment of parkinson's disease and other neurological diseases, today announced the closing of its previously announced merger with a wholly-owned subsidiary of agex therapeutics, inc. the combined company will operate under the name serina therapeutics and will trade on the nyse american market under the ticker symbol “ser” effective with the open of business on wednesday, march 27, 2024. the new cusip number for the combined company following the merger is 81751a108.

iBio, Inc.4 days ago

IBIO AND ASTRALBIO ANNOUNCE TRANSFORMATIVE AI DRUG DISCOVERY COLLABORATION TO RAPIDLY DEVELOP NOVEL ANTIBODIES FOR OBESITY AND CARDIOMETABOLIC DISEASES

News

– leading ai and precision biologics innovators to build a diverse set of novel best-in-class obesity treatments –

Cazoo Group Ltd25 days ago

CAZOO ANNOUNCES TRANSITION TO PURE-PLAY AUTOMOTIVE MARKETPLACE BUSINESS MODEL

News

london & new york--(business wire)--cazoo group ltd (nyse: czoo) (“cazoo” or “the company”), the uk online used car platform which makes buying and selling a car as simple as ordering any other product online, announces its intention to transition to a marketplace business model, leveraging the strength of the cazoo brand and the market-leading ecommerce platform it has built in online automotive retailing for the benefit of the 13,000 car dealers operating in the uk's highly fragmented used ca.

Kintara Therapeutics, Inc.4 days ago

KINTARA THERAPEUTICS ANNOUNCES EXPANSION OF REM-001 CLINICAL STUDY TO INCLUDE PATIENTS ON PEMBROLIZUMAB

News

san diego, march 27, 2024 /prnewswire/ -- kintara therapeutics, inc. (nasdaq: ktra) ("kintara" or the "company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced the expansion of the inclusion criteria in the open label 15- patient rem-001 study in cutaneous metastatic breast cancer (cmbc) to include patients receiving pembrolizumab (keytruda®) for at least three months at screening. cmbc patients are being screened and dosed in the 15-patient study which is evaluating rem-001, a second-generation photodynamic therapy (pdt) photosensitizer agent, and is designed to test the 0.8 mg dose as well as optimize the study design in advance of a phase 3 trial initiation.

REX American Resources Corporation3 days ago

REX AMERICAN RESOURCES REPORTS FULL FISCAL YEAR 2023 NET INCOME PER SHARE ATTRIBUTABLE TO REX COMMON SHAREHOLDERS OF $3.47, THE SECOND HIGHEST IN COMPANY HISTORY

News

dayton, ohio--(business wire)--rex american resources corporation (“rex” or the “company”) (nyse: rex), a leading ethanol production company, today announced financial and operational results for the company's full year and fiscal fourth quarter 2023. rex american resources' q4 and full fiscal year 2023 results principally reflect its interests in six ethanol production facilities. the one earth energy, llc (“one earth”) and nugen energy, llc (“nugen”) ethanol production facilities are consolid.

Erasca, Inc.3 days ago

ERASCA ANNOUNCES $45 MILLION OVERSUBSCRIBED PRIVATE PLACEMENT FINANCING

News

funding from new and existing investors extends anticipated cash runway into h2 2026 funding from new and existing investors extends anticipated cash runway into h2 2026

Mustang Bio, Inc.3 days ago

MUSTANG BIO ANNOUNCES VISION FOR CAR T-CELL THERAPY PLATFORM EXPANSION INTO AUTOIMMUNE DISEASES

News

planning for proof-of concept phase 1 investigator-sponsored clinical trial evaluating mb-106 cd20-targeted car t-cell therapy in autoimmune diseases is underway and expected to initiate in the fourth quarter of 2024

CervoMed Inc.3 days ago

CERVOMED TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

News

boston, march 28, 2024 (globe newswire) -- cervomed inc. (nasdaq: crvo), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that company's management will participate in the following three investor conferences during the month of april:

Nexalin Technology, Inc.3 days ago

NEXALIN TECHNOLOGY ANNOUNCES POSITIVE RESULTS OF CLINICAL STUDY VALIDATING ITS GEN-2 TACS DEVICE FOR REDUCING PAIN AMONG VETERANS WITH MILD TRAUMATIC BRAIN INJURY AT UNIVERSITY OF CALIFORNIA, SAN DIEGO

News

collaborative study involving the va and ucsd achieved statistically significant decrease in pcs and ptsd symptoms versus control group

Molecular Templates, Inc.2 days ago

MOLECULAR TEMPLATES, INC. REPORTS FOURTH QUARTER 2023 FINANCIAL RESULTS AND BUSINESS UPDATE

News

austin, texas, march 29, 2024 (globe newswire) -- molecular templates, inc.(nasdaq: mtem, “molecular templates,” or “mtem”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (“etbs”), to create novel therapies with potent differentiated mechanisms of action for cancer, today reported financial results for the fourth quarter and full year ended december 31, 2023.

Atlas Lithium Corporation3 days ago

ATLAS LITHIUM SECURES US$ 30,000,000 STRATEGIC INVESTMENT AND OFFTAKE AGREEMENT FROM MITSUI

News

boca raton, florida--(newsfile corp. - march 28, 2024) - atlas lithium corporation (nasdaq: atlx), a lithium exploration and development company, is pleased to announce that it has signed definitive investment and offtake agreements with mitsui & co., ltd. ("mitsui") which the company considers as strong validation of its project and team.

Avalon GloboCare Corp.3 days ago

AVALON GLOBOCARE EXTENDS EXCLUSIVITY AGREEMENT TO DISTRIBUTE KETOAIR BREATHALYZER DEVICE AND AI-ENABLED SOFTWARE IN NORTH AMERICA, SOUTH AMERICA, UNITED KINGDOM AND EUROPEAN UNION

News

freehold, n.j., march 28, 2024 (globe newswire) -- avalon globocare corp. (“avalon” or the “company”) (nasdaq: albt), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, is pleased to announce the extension of its exclusive distribution agreement with qi diagnostics limited (“qi diagnostics”) to distribute the ketoair™, a breathalyzer device and related accessories, including current and future models, in key regions including north america, south america, the united kingdom, and the european union.

Sonder Holdings Inc.2 days ago

SOND LOSS ALERT: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, ENCOURAGES SONDER HOLDINGS INC. INVESTORS TO INQUIRE ABOUT SECURITIES CLASS ACTION INVESTIGATION - SOND

News

new york , march 28, 2024 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of sonder holdings inc. (nasdaq: sond) resulting from allegations that sonder may have issued materially misleading business information to the investing public. so what:if you purchased sonder securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Movano Inc.2 months ago

MOVANO HEALTH ANNOUNCES EVIE RINGS NOW SHIPPING

News

pleasanton, calif. , jan. 22, 2024 /prnewswire/ -- movano health (nasdaq: move), a pioneer in health technology, announced that its female first wearable, the evie ring, will begin shipping today.

Nano Labs Ltd13 days ago

NANO LABS ANNOUNCES SECOND HALF OF 2023 FINANCIAL RESULTS

News

hangzhou, china, march 18, 2024 (globe newswire) -- nano labs ltd (nasdaq: na) (“we,” the “company” or “nano labs”), a leading fabless integrated circuit design company and product solution provider in china, today announced its unaudited financial results as of december 31, 2023 and for the six months ended december 31, 2023 second half of 2023 financial highlights net revenue was rmb26.1 million (us$3.7 million) for the second half of 2023, compared to rmb603.0 million in the same period of 2022. gross loss was rmb40.6 million (us$5.7 million) for the second half of 2023, compared to a gross profit of rmb53.8 million in the same period of 2022.

Cue Biopharma, Inc.1 month ago

CUE BIOPHARMA'S LEAD CLINICAL ASSET, CUE-101, TO BE FEATURED AT THE 2024 MULTI-DISCIPLINARY HEAD AND NECK CANCERS SYMPOSIUM

News

boston, feb. 29, 2024 (globe newswire) -- cue biopharma, inc.(nasdaq: cue), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific t cells, announced today that the company's lead clinical asset, cue-101, will be featured in a presentation at the 2024 multi-disciplinary head and neck cancers symposium given by alexander dimitrios colevas, m.d., a principal investigator at stanford university participating in the cue-101 clinical trial. the symposium is being held in phoenix, arizona and virtually from february 29 – march 2, 2024.

Reliance Global Group, Inc.2 months ago

RELI EXCHANGE LAUNCHES THE CLIENT REFERRAL PORTAL INTO ITS PROPRIETARY INSURTECH PLATFORM

News

lakewood, nj, jan. 30, 2024 (globe newswire) -- reliance global group , inc. (nasdaq: reli; reliw) (“reliance” or the “company”), today announced that it has added the reli exchange client referral portal (crp) into its proprietary insurtech platform, reli exchange.

Allego N.V.5 days ago

ALLEGO SCHEDULES CONFERENCE CALL TO DISCUSS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

News

arnhem, netherlands--(business wire)--allego n.v. (“allego” or the “company”) (nyse: allg), a leading pan-european public electric vehicle fast and ultra-fast charging network, today announced it will release the company's fourth quarter and full year 2023 results on tuesday, april 2, 2024, followed by a conference call at 8:30 am et. participants may access the call at 1-877-407-9716, international callers may use 1-201-493-6779 and request to join the allego earnings call. a live webcast will.

Summit Therapeutics Inc.9 days ago

PROMISING INTRACRANIAL ANTI-TUMOR ACTIVITY AND SAFETY DATA FOR IVONESCIMAB IN NSCLC PATIENTS WITH BRAIN METASTASES FEATURED AT ELCC 2024

News

miami--(business wire)---- $smmt--summit therapeutics inc. (nasdaq: smmt) (“summit,” “we,” or the “company”) today announced promising data for its novel, potential first-in-class investigational bispecific antibody, ivonescimab, that is being presented today at the 2024 european lung cancer congress (elcc 2024) in prague, czech republic. two posters featuring updated ivonescimab data will be displayed from 12:00 to 12:45pm central european time. the posters will also be made available on our website aft.

Longeveron Inc.12 days ago

LONGEVERON ANNOUNCES 1-FOR-10 REVERSE STOCK SPLIT

News

miami, march 19, 2024 (globe newswire) -- longeveron inc. (nasdaq: lgvn) (“longeveron” or “company”), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, announced today that the company's board of directors has approved a 1-for-10 reverse split of the company's class a common stock, par value $0.001 per share and class b common stock, par value $0.001 per share (the “common stock”) (the “reverse split”). the reverse split was previously approved by the company's stockholders at a special meeting held on february 21, 2024 the reverse split will legally take effect at 11:59 p.m. eastern time, on march 26, 2024. the company's class a common stock will open for trading under a new cusip number 54303l 203 on the nasdaq capital market on march 27, 2024, on a split-adjusted basis under the current ticker symbol “lgvn.” the reverse split is intended to increase the per share trading price of the company's common stock to enable the company to regain compliance with the minimum bid price requirement for continued listing on the nasdaq capital market.

Keyarch Acquisition Corporation12 days ago

KEYARCH ACQUISITION CORPORATION ANNOUNCES EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO VOTE ON PROPOSED BUSINESS COMBINATION WITH ZOOZ POWER LTD.; FORM F-4 DECLARED EFFECTIVE

News

new york, n.y., march 19, 2024 (globe newswire) -- keyarch acquisition corporation (nasdaq:kych) (“keyarch” or the “company”), a special purpose acquisition company, and zooz power ltd. (“zooz”), a leading provider of flywheel-based power boosting solutions for the ev charging infrastructure market, today jointly announced that the registration statement on form f-4 filed by zooz relating to their proposed business combination was declared effective by the securities and exchange commission (“sec”) on march 18, 2024. keyarch will hold an extraordinary general meeting of its shareholders (the “meeting”) at 9:00 a.m., eastern time, on wednesday, march 27, 2024, for consideration and voting on the approval of the business combination agreement, dated july 30, 2023, as amended (the “definitive agreement”), and related proposals described in the registration statement's proxy statement/prospectus.

PLBY Group, Inc.4 days ago

PLBY GROUP REPORTS FOURTH QUARTER &FULL YEAR 2023 FINANCIAL RESULTS

News

q4 revenue of $39.4 million, net loss of $3.8 million & adjusted ebitda of $1.1 million amends credit facility to eliminate total net leverage covenant until q2 2026 company to hold question-and-answer session at 4:30 pm et today los angeles, march 27, 2024 (globe newswire) -- plby group, inc. (nasdaq: plby) (“plby group” or the “company”), a leading pleasure and leisure lifestyle company and owner of playboy, one of the most recognizable and iconic brands in the world, today provided financial results for the fourth quarter and full year ended december31, 2023. comments from ben kohn, chief executive officer of plby group “in 2023, we worked on five main goals.

Vicarious Surgical Inc.27 days ago

VICARIOUS SURGICAL REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

News

waltham, mass.--(business wire)--vicarious surgical inc. (“vicarious surgical” or the “company”) (nyse: rbot, rbot ws), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter and full year ended december 31, 2023. management will host a corresponding conference call at 4:30 p.m. et today, march 4, 2024. “we made meaningful progress transitioning our beta 2.

RH4 days ago

RH REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS

News

corte madera, calif.--(business wire)--rh (nyse: rh) has released its financial results for the fourth quarter and fiscal year ended february 3, 2024, in a shareholder letter from chairman and chief executive officer gary friedman, available on the investor relations section of its website at ir.rh.com. as previously announced, rh leadership will host a live conference call and audio webcast at 2:00 pm pacific time (5:00 pm eastern time) today. the live conference call may be accessed by dialin.

IT Tech Packaging, Inc.4 days ago

IT TECH PACKAGING, INC. ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS

News

baoding, china , march 27, 2024 /prnewswire/ -- it tech packaging, inc. (nyse american: itp) ("it tech packaging" or the "company"), a leading manufacturer and distributor of diversified paper products innorth china, today announced its unaudited financial results for the fourthquarterand audited financial results for the fiscal yearendeddecember 31, 2023. mr. zhenyong liu, chairman and chief executive officer of the company, commented, " in 2023, the company achieved a revenue of $86.55 million and a gross profit of $1.00 million.

Asensus Surgical, Inc.10 days ago

ASENSUS SURGICAL, INC. REPORTS OPERATING AND FINANCIAL RESULTS FOR THEFOURTH QUARTER 2023 AND FULL YEAR 2023

News

research triangle park, n.c., march 21, 2024 (globe newswire) -- asensus surgical , inc. (nyse american: asxc), a medical device company that is digitizing the interface between the surgeon and the patient, announced its operating and financial results for the fourth quarter and full year 2023.

Akebia Therapeutics, Inc.3 days ago

AKEBIA RECEIVES FDA APPROVAL OF VAFSEO® (VADADUSTAT) TABLETS FOR THE TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE IN ADULT PATIENTS ON DIALYSIS

News

once-daily oral hif-ph inhibitor activates physiologic response to manage anemia akebia's launch strategy developed to drive toward a potential new oral standard of care company to host conference call on thursday, march 28 at 8:00 am et cambridge, mass. , march 27, 2024 /prnewswire/ -- akebia therapeutics ® , inc. (nasdaq: akba), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the u.s. food and drug administration (fda) has approved vafseo® (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (ckd) in adults who have been receiving dialysis for at least three months.

Alternus Clean Energy, Inc.24 days ago

ALTERNUS CLEAN ENERGY TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES AND INDUSTRY EVENTS

News

fort mill, s.c., march 07, 2024 (globe newswire) -- alternus clean energy (nasdaq: alce) (“alternus” or the “company”), a leading utility-scale transatlantic, clean energy independent power producer (ipp) today announced its participation in various industry events and investor conferences over the next several months.

LeddarTech Holdings Inc.3 days ago

LEDDARTECH SCHEDULED TO PRESENT TO INVESTORS AT THE EMERGING GROWTH CONFERENCE AT NOON EDT ON APRIL 4, 2024

News

quebec city, march 28, 2024 /prnewswire/ -leddartech holdings inc. ("leddartech") (nasdaq: ldtc), an automotive software company that provides patented disruptive ai-based low-level sensor fusion and perception software technology, leddarvision™, for adas, ad and parking applications, is pleased to announce that it is scheduled to present at the emerging growth conference on april 4, 2024 from 12:00-12:30 edt. the emerging growth conference, a prestigious event that brings together innovative companies and influential investors, will be held on april 3-4, 2024.

SRIVARU Holding Limited4 days ago

SRIVARU'S (SVMH) PRANA 2.0 INTELLIGENT BATTERY SYSTEM GOES LONGER AND FURTHER: SRIVARU SUCCESSFULLY COMPLETES ROAD/PERFORMANCE TESTING

News

prana 2.0 grand and elite featuring the company's version 2.0 intelligent battery system extends on-road driving* range to 150km and 250km/charge; 2-4 times longer range than the average daily commute distance prana 2.0 grand and elite featuring the company's version 2.0 intelligent battery system extends on-road driving* range to 150km and 250km/charge; 2-4 times longer range than the average daily commute distance

Syra Health Corp.3 days ago

SYRA HEALTH SECURES STATEWIDE HEALTHCARE CONTRACT IN MISSOURI

News

syra has expanded its services to 18 states carmel, ind. , march 28, 2024 /prnewswire/ --syra health corp. (nasdaq: syra),a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today it has secured a healthcare workforce contract in missouri for providing temporary medical services personnel.

A2Z Smart Technologies Corp.9 days ago

A2Z SMART TECHNOLOGIES CORP. ANNOUNCES FIRST DEPLOYMENT OF NEW GENERATION SMART CARTS

News

tel aviv, israel / accesswire / march 22, 2024 / a2z smart technologies corp. ("a2z" or the "company") (nasdaq:az), a global leader of advanced proved-in-use smart cart solutions, announced today that it is starting to fulfill its backlog of orders of its new generation cust2mate 3.0 smart carts. the first deployment is scheduled to start in april, at the yochananof supermarket chain, one of the largest retail chains in israel, with deployments at morton williams, monoprix and others, to follow.

Verint Systems Inc.4 days ago

VERINT ANNOUNCES Q4 FYE 2024 RESULTS

News

melville, n.y.--(business wire)--verint® (nasdaq: vrnt), the customer engagement company™, today announced results for the three months and year ended january 31, 2024 (fye 2024). revenue for the three months ended january 31, 2024 was $265 million, representing 12% year-over-year growth. revenue for the year ended january 31, 2024 was $910 million on a gaap basis and $911 million on a non-gaap basis. for the three months ended january 31, 2024, diluted eps was $0.37 on a gaap basis and $1.07 o.

ProMIS Neurosciences Inc.20 days ago

PROMIS NEUROSCIENCES STRENGTHENS GLOBAL INTELLECTUAL PROPERTY PORTFOLIO

News

adds key u.s. and international patent allowances to further protect the company's monoclonal antibody therapeutic for the treatment of alzheimer's disease adds key u.s. and international patent allowances to further protect the company's monoclonal antibody therapeutic for the treatment of alzheimer's disease

Scholar Rock Holding Corporation12 days ago

SCHOLAR ROCK REPORTS FULL YEAR 2023 FINANCIAL RESULTS AND HIGHLIGHTS BUSINESS PROGRESS

News

cambridge, mass.--(business wire)--scholar rock (nasdaq: srrk), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (sma), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today reported financial results and corporate updates for the full year ended december 31, 2023. “in 2023, scholar rock made significant progress across our industry-leading antimyostatin pipeline, and we are.

Golden Minerals Company4 days ago

GOLDEN MINERALS ANNOUNCES RETURN OF EL QUEVAR SILVER PROJECT

News

golden, colo.--(business wire)---- $aumn #gold--golden minerals company (“golden minerals,” “golden” or the “company”) (nyse-a: aumn and tsx: aumn) announced today that barrick gold corporation (“barrick”) notified the company it is withdrawing from an earn-in agreement (the “agreement”) on the el quevar silver project (salta province, argentina) which the two parties signed in april 2020. the termination will be effective on april 20, 2024. golden minerals president and chief executive officer, warren rehn, c.

Vaccinex, Inc.4 days ago

VACCINEX, INC. ANNOUNCES $1.5 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES

News

rochester, n.y., march 27, 2024 (globe newswire) -- vaccinex, inc. (nasdaq: vcnx) (“vaccinex” or the “company”), a clinical-stage biotechnology company pioneering a differentiated approach to treating alzheimer's disease and cancer through the inhibition of sema4d, today announced that it has entered into definitive agreements with certain institutional investors for the purchase and sale of 193,000 shares of its common stock in a registered direct offering together with warrants to purchase up to an aggregate of 193,000 shares of common stock in a concurrent private placement priced at-the-market under nasdaq rules at a combined purchase price of $7.77 per share and accompanying warrant. the warrants will have an exercise price of $7.64 per share, will be immediately exercisable upon issuance and will expire 5 years from the initial exercise date. the registered direct offering and concurrent private placement are referred to herein as the “transactions.”

Alset Inc.4 months ago

ALSET INC. ANNOUNCES EXECUTION OF BINDING TERM SHEET TO ACQUIRE 41.5% INTEREST IN COMPANY ENGAGED IN DISTRIBUTION OF ELECTRIC VEHICLES AND CHARGING STATIONS

News

bethesda, md, dec. 13, 2023 (globe newswire) -- alset inc. (nasdaq:aei) ("aei" or the "company"), a diversified holding company principally engaged through its subsidiaries in the development of smart and sustainable home communities and other property development, financial services, digital transformation technologies, biohealth activities and consumer products, is pleased to announce the signing of a binding term sheet to acquire 100% of new energy asia pacific inc. (“neapi”). neapi owns approximately 41.5% of new energy asia pacific limited, a hong kong company (“new energy”). new energy focuses on distributing all-electric versions of special-purpose and transportation vehicles, charging stations and batteries.

B. Riley Financial, Inc.6 days ago

B. RILEY FINANCIAL, INC. SUED FOR SECURITIES LAW VIOLATIONS - INVESTORS SHOULD CONTACT LEVI & KORSINSKY FOR MORE INFORMATION - RILY

News

new york, ny / accesswire / march 25, 2024 / if you suffered a loss on your b. riley financial, inc. (nasdaq:rily) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/b-riley-lawsuit-submission-form?prid=72617&wire=1 or contact joseph e.

Energous Corporation3 days ago

ENERGOUS CORPORATION REPORTS 2023 RESULTS

News

san jose, calif.--(business wire)--energous corporation (nasdaq: watt), a leading developer of rf-based charging for wireless power networks, today announced financial results for the year ended december 31, 2023, and provided an update on recent partnerships and company highlights. 2023 financial results 2023 revenue of approximately $0.5 million versus $0.9 million in 2022. total costs and expenses were significantly reduced in 2023 from approximately $27.5 million in 2022 to approximately $2.

Sprinklr, Inc.3 days ago

SPRINKLR APPOINTS AMITABH MISRA AS CHIEF TECHNOLOGY OFFICER

News

new york--(business wire)---- $cxm #cx--sprinklr (nyse: cxm), the unified customer experience management (unified-cxm) platform for modern enterprises, announced the appointment of amitabh misra as chief technology officer (cto), effective april 1, 2024. misra will lead all r&d teams across the globe including product and engineering at sprinklr. he joins the executive leadership team to share his passion for innovative technology to help the company grow and scale. he will report directly to sprinklr f.

Consolidated Water Co. Ltd.4 days ago

CONSOLIDATED WATER REPORTS 2023 REVENUE UP 92% TO $180.2 MILLION, NET INCOME OF $30.7 MILLION OR $1.93 PER DILUTED SHARE

News

“in 2023, our strong revenue and earnings growth made it the best-performing year ever for consolidated water,” stated company ceo, rick mctaggart.

GigaCloud Technology Inc4 days ago

GIGACLOUD TECHNOLOGY INC FILES ANNUAL REPORT ON FORM 10-K FOR FISCAL YEAR 2023

News

el monte, calif., march 27, 2024 (globe newswire) -- gigacloud technology inc (nasdaq: gct) (“gigacloud” or the “company”), a pioneer of global end-to-end b2b ecommerce solutions for large parcel merchandise, today announced that on march 27, 2024, the company filed its annual report on form 10-k for the fiscal year ended december 31, 2023 with the u.s. securities and exchange commission (the “sec”).

Veru Inc.9 days ago

VERU RESCHEDULES ANNUAL MEETING OF SHAREHOLDERS

News

--restated historical financial statements expected to be filed no later than april 15, 2024-- --2024 annual meeting of shareholders to follow financial statements filings--

Andretti Acquisition Corp.3 days ago

ZAPATA AI AND ANDRETTI ACQUISITION CORP. ANNOUNCE CLOSING OF BUSINESS COMBINATION

News

boston & indianapolis--(business wire)--zapata computing, inc. (“zapata ai”), the industrial generative ai software company developing solutions to solve enterprises' most difficult, industrial-scale problems, announced today that it has completed its business combination with andretti acquisition corp. (nyse: wnnr), a special purpose acquisition company. the combined company, which was renamed zapata computing holdings inc., will operate as zapata ai and its common stock and warrants will begi.

Expion360 Inc.3 days ago

EXPION360 REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

News

innovative new products & customization form factors with leading rv oems expected to position company for increased market share & revenue growth in 2024 fortified balance sheet enables company to expand revenue profile with newly launched home energy storage systems (ess) 2024 anticipated milestones include: new strategic partnerships, oem expansion and disruptive product launches across multiple market segments redmond, ore., march 28, 2024 (globe newswire) -- expion360 inc.(nasdaq: xpon) (“expion360” or the “company”), an industry leader in lithium-ion battery power storage solutions, today reported its financial and operational results for the fourth quarter and full year ended december 31, 2023.

1847 Holdings LLC5 days ago

1847 REMINDS SHAREHOLDERS TO VISIT THE COMPANY'S WEBSITE TO RECEIVE SCHEDULE K-1 ELECTRONICALLY

News

new york, ny / accesswire / march 26, 2024 / 1847 holdings llc("1847" or the "company") (nyse american:efsh), a unique holding company that combines the attractive attributes of owning private, lower-middle market businesses with the liquidity and transparency of a publicly traded company, reminds shareholders to visit the company's website at https://portal.1847holdings.com/login, if you would like to receive an electronic copy of your schedule k-1. if you do not register to receive a copy of the schedule k-1 electronically, a hard copy of your schedule k-1 will be mailed to the address on record.

China Automotive Systems, Inc.3 days ago

CHINA AUTOMOTIVE SYSTEMS REPORTS RECORD ANNUAL REVENUE, AND A 81.2% INCREASE IN DILUTED NET INCOME PER SHARE TO $1.25 IN FISCAL YEAR 2023

News

- electric power steering ("eps") sales increased by 24.6% in 2023 - wuhan, china , march 28, 2024 /prnewswire/ -- china automotive systems, inc. (nasdaq: caas) ("caas" or the "company"), a leading power steering components and systems supplier in china, today announced its unaudited financial results for the fourth quarter and the audited results for the fiscal year ended december 31, 2023. fourth quarter 2023 highlights net sales increased by 23.6% year-over-year to $159.2 million gross profit increased by 38.8% to $34.7 million from $25.0 million.

Janover Inc.3 days ago

JANOVER REPORTS FISCAL 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

News

reports 54% increase in revenue per transaction in 2023 revenue from small business transactions grows more than 100% for second consecutive year boca raton, fla., march 28, 2024 (globe newswire) -- janover inc. (nasdaq: jnvr) (“janover” or the “company”), an ai-enabled platform for commercial real estate transactions, today provided a business update, and announced its financial results for the year-ended december 31, 2023.

Quantum Corporation6 days ago

QUANTUM PROVIDES BUSINESS UPDATE

News

san jose, calif.--(business wire)--quantum corporation (nasdaq: qmco) ("quantum" or the "company"), the pioneer in end-to-end data management solutions designed for the ai era, today filed a form 8-k regarding several business updates, including reiterating its efforts to be current with its sec financial reports by may 7, 2024. on march 19, 2024, the company received a letter (the “letter”) from the listing qualifications staff (the “staff”) of the nasdaq stock market llc (“nasdaq”) regarding.

Millennium Group International Holdings Limited4 months ago

MILLENNIUM GROUP MANAGEMENT ATTENDS BEAUTYWORLD MIDDLE EAST IN DUBAI

News

management focuses on significant opportunities for the company's packaging business with the fast-growing beauty and cosmetics industry in the middle east region management focuses on significant opportunities for the company's packaging business with the fast-growing beauty and cosmetics industry in the middle east region

NFT Limited6 months ago

NFT LTD. ANNOUNCES RECEIPT OF NYSE AMERICAN CONTINUED LISTING STANDARD NONCOMPLIANCE NOTICE

News

hong kong, sept. 22, 2023 (globe newswire) -- nft ltd. (nyse american: mi) (“company” or “nft”, formerly known as takung art co., ltd.), as an emerging online trading platform operator of international art and collectibles, today announced that it had received a deficiency letter (“letter”) from nyse american llc (“nyse american” or the “exchange”) on september 19, 2023 stating that the company is not in compliance with the continued listing standards as set forth in section 1003(f)(v) of the nyse american company guide (“company guide”).

InMed Pharmaceuticals Inc.11 days ago

INMED GRANTED 180-DAY EXTENSION TO ACHIEVE NASDAQ MINIMUM BID COMPLIANCE

News

vancouver, british columbia--(newsfile corp. - march 20, 2024) - inmed pharmaceuticals inc. (nasdaq: inm) ("inmed" or the "company"), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today announced that it has received a notification letter from the listing qualifications department of nasdaq stock market llc ("nasdaq") that the company has been granted an additional 180-day compliance period, or until september 16, 2024 (the "extended compliance period"), to regain compliance with nasdaq's minimum bid price requirement for the continued listing on the nasdaq capital market, as set forth in nasdaq listing rule 5550(a)(2) (the "minimum bid price rule"). nasdaq's determination is based on the company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the nasdaq capital market, with the exception of the bid price requirement, and the company's written notice of its intention to consider all available options to regain compliance during the extended compliance period, including, if necessary, effecting a reverse stock split.

Vocodia Holdings Corp.3 days ago

VOCODIA LAUNCHES PILOT PROGRAM WITH MAJOR UTILITY PROVIDER

News

company's conversational ai to provide 3rd party verification for switching energy providers chicago,march 28, 2024 — vocodia holdings corp.

Lands' End, Inc.4 days ago

LANDS' END ANNOUNCES FOURTH QUARTER AND FULL YEAR FISCAL 2023 RESULTS

News

increases gross profit by 13.5% and gross margin by 550 basis points compared to the fourth quarter fiscal 2022 provides fiscal 2024 outlook

ThermoGenesis Holdings, Inc.5 months ago

THERMOGENESIS HOLDINGS ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

News

conference call to be held today at 1:30 p.m. pt/4:30 p.m.

Signing Day Sports, Inc.1 month ago

SIGNING DAY SPORTS INTRODUCES BRANDED APPAREL LINE CATERING TO THE NEEDS OF ATHLETES AT EVERY LEVEL

News

initial launch includes pre-scrunched socks and leg sleeves, streamer towels, and co-branded u.s. army bowl performance shirts providing athletes with superior comfort and mobility

Rent the Runway, Inc.5 days ago

RENT THE RUNWAY ANNOUNCES 1-FOR-20 REVERSE STOCK SPLIT

News

new york, march 26, 2024 (globe newswire) -- rent the runway, inc. (“rent the runway” or the “rtr”) (nasdaq: rent) today announced that it will proceed with a 1-for-20 reverse stock split (“reverse stock split”) of its outstanding shares of class a common stock and class b common stock (collectively, the “common stock”) following approval by its board of directors. this ratio is within the ratio range approved by stockholders at a special meeting of rtr shareholders held on march 21, 2024.

Opko Health, Inc.3 days ago

LABCORP ANNOUNCES ACQUISITION OF SELECT ASSETS OF BIOREFERENCE HEALTH'S DIAGNOSTICS BUSINESS

News

transaction to enhance labcorp's laboratory services network and expand access to the company's high-quality clinical laboratory services burlington, n.c. and miami , march 28, 2024 /prnewswire/ --labcorp(nyse: lh), a global leader of innovative and comprehensive laboratory services, and opko health, inc. (nasdaq: opk), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for labcorp to acquire select assets of bioreference health, a wholly owned subsidiary of opko health.

VBI Vaccines, Inc.2 months ago

VBI ANNOUNCES AGREEMENT TO SELL MANUFACTURING CAPABILITIES, CERTAIN RELATED ASSETS, AND ENTER INTO NEW LICENSE AGREEMENT WITH BRII BIOSCIENCES

News

cambridge, mass.--(business wire)--vbi vaccines inc. (nasdaq: vbiv) (“vbi” or the “company”), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced agreements whereby brii biosciences (“brii bio”), subject to certain activities, is expected to: (i) acquire the intellectual property for vbi-2601, vbi's hbv immunotherapeutic development program, and eliminate payment obligations from the july 2023 agreements between vbi an.

Cheche Group Inc.3 days ago

CHECHE GROUP ANNOUNCES PARTNERSHIP WITH THE INSURANCE BROKERAGE FIRM IN XIAOMI GROUP

News

beijing , march 28, 2024 /prnewswire/ -- cheche group inc. (nasdaq: ccg) ("cheche" or the "company"), china's leading auto insurance technology platform, today announced it has entered into a partnership with beijing houji insurance brokerage co., ltd. ("beijing houji"), an affiliate of xiaomi corporation ("xiaomi group"), as cheche continues to broaden its partner network with leaders in the new energy vehicle ("nev") industry.

Eastside Distilling, Inc.4 days ago

EASTSIDE DISTILLING, INC. TO REPORT 2023 FISCAL YEAR RESULTS ON MONDAY, APRIL 1, 2024

News

portland, ore. , march 27, 2024 /prnewswire/ -- eastside distilling, inc. (nasdaq: east) ("eastside" or the "company"), a consumer-focused beverage company that builds craft inspired experiential brands and high-quality artisan products around premium spirits, digital can printing, co-packing and mobile filling, will report its financial year end results after the market close on monday, april 1, 2024.

INVO BioScience, Inc.4 months ago

NAYA BIOSCIENCES ANNOUNCES PUBLICATION OF NEW DATA FOR ITS CD38-TARGETED FLEX-NK™ BISPECIFIC ANTIBODY IN THE AMERICAN SOCIETY OF HEMATOLOGY'S BLOOD JOURNAL

News

abstract from 2023 american society of hematology (ash) meeting data demonstrates differentiated profile from darzalex® (daratumumab) with best-in-class potential, supports initiation of clinical trials in 2024 naya expects to close its previously announced merger with invo bioscience (nasdaq: invo) in the first quarter of 2024 aventura, fla. and sarasota, fla.

WeTrade Group Inc.2 months ago

WETRADE GROUP INC'S WHOLLY-OWNED SUBSIDIARY AND WHOLLY-OWNED HOLDING COMPANY IN CHINESE MAINLAND WILL JOINTLY PURSUE CLAIMS UNDER LITIGATION AGAINST IT

News

beijing, jan. 31, 2024 (globe newswire) -- wetrade information technology limited, a wholly-owned subsidiary of wetrade group inc.（wetg.us）in hong kong, and beijing yueshang digital technology group co., ltd, a wholly-owned subsidiary of china, jointly declare that:the announcement made by wetrade group inc.on november 21, 2023 that the two companies have been sold is not true. the two companies will file a lawsuit through legal and demand economic compensation from wetrade group inc.mr. hechunwei, the former ceo of wetrade group inc., also stated in his clarification letterthat during his tenure as ceo ofwetrade group inc., he did not sighany announcement to sell these two companies.

Iterum Therapeutics plc3 days ago

ITERUM THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

News

- -resubmission of nda on track for early q2 24— - -cash runway into 2025, including through potential fda approval in early q4 24-- --company to host conference call today at 8:30amet-- dublin, ireland and chicago, march 28, 2024 (globe newswire) -- iterum therapeutics plc (nasdaq: itrm), a clinical-stage pharmaceutical company focused on developing next generation oral and iv antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today reported financial results for the fourth quarter and year ended december 31, 2023. “since we announced positive topline data from our reassure trial in january, we've made significant progress in completing the new drug application (nda) for the planned resubmission early in the second quarter,” said corey fishman, iterum's chief executive officer.

First Bank3 days ago

FIRST BANK ANNOUNCES FIRST QUARTER 2024 EARNINGS CONFERENCE CALL

News

hamilton, n.j., march 28, 2024 (globe newswire) -- first bank (nasdaq global market: frba) invites participation in a conference call to discuss the company's financial and operating performance during its first quarter ended march 31, 2024.

Skillz Inc.17 days ago

SKILLZ REPORTS 2023 FOURTH QUARTER AND FULL YEAR 2023 RESULTS

News

las vegas--(business wire)--skillz inc. (nyse: sklz) (“skillz” or the “company”), the leading mobile games platform bringing fair competition to players worldwide, today reported financial results for the fourth quarter and fiscal year ended december 31, 2023. fourth quarter 2023 financial highlights: revenue of $29.1 million gross profit of $25.7 million net loss of $20.8 million adjusted ebitda1 of $(12.3) million paying monthly active users (pmau)2 of 137,000 average revenue per paying month.

Spectral AI, Inc.4 days ago

SPECTRAL AI ANNOUNCES 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS

News

2023 research & development revenue of $18.1 million expected to increase to $28.0 million in 2024

Surf Air Mobility Inc.3 days ago

SURF AIR MOBILITY REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR ENDED DECEMBER 31, 2023

News

los angeles--(business wire)--surf air mobility inc. (nyse: srfm), a leading regional air mobility platform, today reported its fourth quarter and full year results. please visit the surf air mobility investor relations website at investors.surfair.com for more information and to listen to the accompanying earnings call at 5:00 pm eastern time. “we are pleased to have beat our revenue guidance and achieved our adjusted ebitda guidance for the year. additionally, we've achieved two significant m.

AIM ImmunoTech Inc.3 days ago

AIM IMMUNOTECH TO PRESENT AT THE MEDINVEST BIOTECH & PHARMA INVESTOR CONFERENCE

News

ocala, fla., march 28, 2024 (globe newswire) -- aim immunotech inc. (nyse american: aim)(“aim” or the “company”) today announced that thomas k.

View, Inc.5 months ago

RXR SELECTS VIEW SMART WINDOWS FOR 89 DEKALB AVENUE IN BROOKLYN, NY, THE SECOND RXR MULTIFAMILY DEVELOPMENT TO FEATURE VIEW

News

milpitas, calif., nov. 14, 2023 (globe newswire) -- view, inc. (nasdaq: view) (“view”), the leader in smart building technologies, announced that its smart windows will envelop 89 dekalb avenue, rxr's 324-unit multifamily development in brooklyn, new york. this marks view's second multifamily project with rxr, following hamilton green, a 684,000 square feet mixed-use development that will include 477 residential units, in white plains, new york.

ReShape Lifesciences, Inc.3 days ago

RESHAPE LIFESCIENCES® RECEIVES NOTICE OF ALLOWANCE FOR ADDITIONAL U.S. PATENT RELATED TO AN INTRAGASTRIC BALLOON SYSTEM

News

irvine, calif., march 28, 2024 (globe newswire) -- reshape lifesciences® (nasdaq: rsls), the premier physician-led weight loss and metabolic health-solutions company, today announced that the company has received a notice of allowance from the u.s. patent and trademark office (uspto) for patent application 18/370,819, entitled, “intragastric device.

SI-BONE, Inc.27 days ago

SI-BONE TO PRESENT AT BARCLAYS 26TH ANNUAL GLOBAL HEALTHCARE CONFERENCE ON MARCH 12, 2024

News

santa clara, calif., march 04, 2024 (globe newswire) -- si-bone, inc. (nasdaq: sibn), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming barclays 26th annual global healthcare conference in miami. management will be hosting a fireside chat on tuesday, march 12, at 8:30 a.m. eastern time / 5:30 a.m. pacific time.

Reborn Coffee, Inc.3 days ago

REBORN COFFEE REPORTS FISCAL YEAR 2023 FINANCIAL RESULTS

News

fy 2023 record revenue increased 84% to $6.0 million fy 2023 gross profit increased 93% to $1.9 million brea, calif., march 28, 2024 (globe newswire) -- reborn coffee, inc. (nasdaq: rebn) ("reborn", or the "company"), a california-based retailer of specialty coffee, has reported its financial and operational results for the fiscal year ended december 31, 2023.

Alignment Healthcare, Inc.12 days ago

SHAREHOLDER ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF ALIGNMENT HEALTHCARE, INC. - ALHC

News

new york , march 19, 2024 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of alignment healthcare, inc. ("alignment"or the "company")(nasdaq: alhc). such investors are advised to contact danielle peyton at newaction@pomlaw.comor 646-581-9980, ext.

Carisma Therapeutics, Inc.10 days ago

CARISMA ANNOUNCES UPCOMING PRESENTATIONS AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) ANNUAL MEETING

News

philadelphia , march 21, 2024 /prnewswire/ -- carisma therapeutics inc.(nasdaq: carm) ("carisma" or the "company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced its upcoming presentations at the american association for cancer research (aacr) annual meeting taking place from april 5-10, 2024, in san diego, california. the poster presentation will showcase preclinical data illustrating the advancements made with carisma's proprietary engineered microenvironment converters (em-c) platform.

Marpai, Inc.5 days ago

MARPAI REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

News

full year benefit of maestro acquisition and q4 corrective actions driving financial improvement tampa, fla. , march 26, 2024 /prnewswire/ --marpai,inc. ("marpai" or the "company") (nasdaq: mrai),an independent national third-party administration (tpa) company transforming the $22 billion tpa market supporting self-funded employer health plans with affordable, intelligent healthcare, today announced financial results for the fourth quarter and fiscal year 2023.

ARS Pharmaceuticals, Inc.5 days ago

SPRY ALERT: LEVI & KORSINSKY REMINDS INVESTORS OF AN INVESTIGATION INVOLVING POSSIBLE SECURITIES FRAUD VIOLATIONS BY ARS PHARMACEUTICALS, INC.

News

new york, ny / accesswire / march 26, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of ars pharmaceuticals, inc. ("ars") (nasdaq:spry) concerning possible violations of federal securities laws. on september 19, 2023, ars announced it received from the food and drug administration (fda) a complete response letter (crl) concerning ars' "neffy.

Cartesian Therapeutics, Inc.3 days ago

CARTESIAN THERAPEUTICS ANNOUNCES APPROVAL OF CONVERSION OF SERIES A CONVERTIBLE PREFERRED STOCK AND PLANS TO EFFECT REVERSE STOCK SPLIT

News

proposals approved at company's special meeting of stockholders held march 27, 2024 proposals approved at company's special meeting of stockholders held march 27, 2024

Solid Biosciences Inc.18 days ago

SOLID BIOSCIENCES PROVIDES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS UPDATE AND FINANCIAL RESULTS

News

— company ends 2023 with approximately $123.6 million in cash and investments. combined with gross proceeds from $108.9 million private placement in january, solid has anticipated cash runway into 2026 —

Nikola Corporation10 days ago

NIKOLA CELEBRATES GRAND OPENING OF FIRST HYLA REFUELING STATION IN SOUTHERN CALIFORNIA

News

ontario-based station marks a significant step forward in establishing comprehensive hydrogen refueling network for class 8 trucks phoenix , march 21, 2024 /prnewswire/ -- nikola corporation (nasdaq: nkla), a global leader in zero-emissions transportation and energy supply and infrastructure solutions, via the hyla brand, celebrated the grand opening of its inaugural hyla high-pressure modular refueling station and facility in southern calif. the celebration welcomed fleet customers, dealers from nikola's sales and service network, government officials, industry press and members of the nikola leadership and engineering teams, each playing an integral role in the realization of this achievement.

Gevo, Inc.24 days ago

GEVO REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

News

englewood, colo., march 07, 2024 (globe newswire) -- gevo, inc. (nasdaq: gevo) (“gevo”, the “company”, “we”, “us” or “our”) today announced financial results for the fourth quarter and full year 2023 and recent corporate highlights.

MIRA Pharmaceuticals, Inc.10 days ago

MIRA PHARMACEUTICALS WELCOMES DR. ITZCHAK ANGEL, FORMER HEAD OF PHARMACOLOGY AT SYNTHELABO, AS CHIEF SCIENTIFIC ADVISOR

News

a seasoned pharmaceutical industry executive with over 40 years at the forefront of innovation, including at synthelabo (acquired by sanofi-aventis), dr. angel aims to propel mira pharmaceuticals' mission to tackle unmet needs in neurologic and neuropsychiatric disorders miami , march 21, 2024 /prnewswire/ -- mira pharmaceuticals inc. (nasdaq: mira) ("mira" or the "company"), an innovative pre-clinical-stage pharmaceutical company focused on the development of novel treatments for neurologic and neuropsychiatric disorders, proudly announces the appointment of distinguished pharmaceutical executive dr. itzchak angel as its new chief scientific advisor. dr. angel brings over 40 years of preclinical, clinical and regulatory acumen to mira.

Smith Micro Software, Inc.1 month ago

SMITH MICRO REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS

News

pittsburgh--(business wire)---- $smsi #saas--smith micro software, inc. (nasdaq: smsi) (“smith micro” or the “company”) today reported financial results for its fourth quarter and fiscal year ended december 31, 2023. “looking back at 2023, we faced some challenges and implemented decisive changes to build a new path forward for the company,” said william w. smith, jr., president, chief executive officer, and chairman of the board of smith micro. “i believe we are well positioned to capitalize on what is happen.

Nortech Systems Incorporated11 days ago

NORTECH SYSTEMS REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS

News

minneapolis--(business wire)-- #nsys--nortech systems incorporated (nasdaq: nsys) (“nortech” or, the "company"), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical, industrial and defense markets, reported 2023 fourth quarter and full year results for the period ended december 31, 2023. 2023 highlights: net sales of $139.3 million, up 3.9% from the prior year. net income of $6.9 million, or $2.38 per diluted share,.

Nutriband Inc.6 days ago

NUTRIBAND ANNOUNCES DATA SUPPORTING NEED FOR SAFER ABUSE-DETERRENT TRANSDERMAL PATCHES PRESENTED AT 2024 AMERICAN ACADEMY OF PAIN MEDICINE ANNUAL MEETING

News

data highlights the incidence of abuse and accidental pediatric exposure of transdermal patches containing opioid and stimulant drugs nutriband's aversa™ technology addresses the unmet need for safer abuse-deterrent transdermal patches orlando, fl / accesswire / march 25, 2024 / nutriband inc. (nasdaq:ntrb)(nasdaq:ntrbw), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that data on the incidence of transdermal patch abuse and accidental pediatric exposure was presented at the 2024 american academy of pain medicine (aapm) annual meeting on march 8, 2024. the american academy of pain medicine (aapm) is dedicated to advancing multidisciplinary pain care, education, advocacy, and research.

Allarity Therapeutics, Inc.4 days ago

ALLARITY THERAPEUTICS MAKES STRATEGIC PIVOT TO FOCUS SOLELY ON ACCELERATING STENOPARIB TOWARD REGULATORY APPROVAL IN ADVANCED RECURRENT OVARIAN CANCER

News

the stenoparib phase 2 monotherapy trial in advanced, recurrent ovarian cancer continues to show promise, prompting shift in resources to accelerate stenoparib development further development of ixempra ® and dovitinib is de-prioritized the company has been able to reduce costs materially boston (march 27, 2024) — allarity therapeutics, inc. (“allarity” or the “company”) (nasdaq: allr), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced a strategic pivot aimed at advancing its clinical-stage candidate stenoparib, a novel parp/tankyrase dual inhibitor, toward registration in advanced recurrent ovarian cancer, leveraging its drp® platform to identify and enroll only the patients most likely to derive clinical benefit. this decision is the outcome of an extensive analysis of the company's strategic opportunities, initiated immediately after thomas jensen stepped into his role as interim ceo in early december 2023.

Vaxart, Inc. - Common Stock4 days ago

VAXART TO PRESENT AT WORLD VACCINE CONGRESS WASHINGTON 2024 ON APRIL 3

News

south san francisco, calif., march 27, 2024 (globe newswire) -- vaxart, inc. (nasdaq: vxrt) today announced that dr. sean tucker, founder and chief scientific officer, will present at the world vaccine congress washington 2024 in washington, d.c. on wednesday, april 3, 2024. the company has appeared repeatedly at the annual event in washington, d.c.

Triumph Group, Inc.23 days ago

TRIUMPH UPDATES FINANCIAL GUIDANCE FOR FULL YEAR FISCAL 2024

News

radnor, pa., march 8, 2024 /prnewswire/ -- triumph group, inc. (nyse: tgi) ("triumph" or the "company") announced today that it has updated itsfinancial guidance for its full year fiscal 2024, which ends march 31, 2024, in conjunction with the recent closing on the sale of its former product support business and the related expected paydowns of its debt.

Processa Pharmaceuticals, Inc.3 days ago

PROCESSA PHARMACEUTICALS TO PRESENT AT THE MEDINVEST BIOTECH AND PHARMA INVESTOR CONFERENCE

News

hanover, md, march 28, 2024 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa) (“processa” or the “company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that george ng, chief executive officer, will present a corporate update at the medinvest biotech and pharma investor conference. david young, processa's president of research & development, will participate virtually.

OMNIQ Corp.2 days ago

OMNIQ SCHEDULES FOURTH-QUARTER 2023 EARNINGS CALL

News

salt lake city, march 28, 2024 (globe newswire) -- omniq corp. (nasdaq: omqs) (“omniq” or the “company”), a provider of artificial intelligence (ai) and iot–based solutions will release full year 2023 earnings after the market close onmonday, april 1st, 2024. the announcementwill be followed by a live earnings call with managementthe following morning,tuesday, april 2nd, 2024 at 9:00 am est.